AzTrials
AzTrials

FamilyFAMPARTNCT04957394

Pilot Trial of Family Partner - a Child Maltreatment Prevention Intervention

A study testing Family Partner in people with Family and Parenting, run by Oslo Metropolitan University at 3 sites in Norway.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Prior to this pilot study, it is unclear whether comparing a manualized version of the Family Partner Model to standard practice in the Child Welfare Services would be feasible. Results will inform whether and how to design a fully powered randomized controlled trial to test the effects of a manualized version of the… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Family, Parenting, Child Maltreatment
What is being tested?
Family Partner
Could I receive a placebo?
No, everyone receives an active treatment
How many people
45 participants
Where
3 sitesNorway
Study dates
1 Jan 2022to 18 Sep 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • parents are 18 years or older, and
  • children are under 18 years, and
  • families with complex challenges who are already involved in the Child Welfare Services, and
  • children live under potentially harmful circumstances, and
  • parents struggle in several areas, e.g. employment, poverty, drug misuse, mental health

Who cannot join

  • None

Trial locations and contacts

3 sites in 1 country.

Norway3 sites
  • Øvre Eiker kommune

    Drammen

  • Larvik kommune

    Larvik

  • Lillehammer kommune

    Lillehammer

Other trials in Norway

About this study

Official title: Family Partner -Co-development, Implementation and Evaluation of a Child Maltreatment Prevention Intervention

Prior to this pilot study, it is unclear whether comparing a manualized version of the Family Partner Model to standard practice in the Child Welfare Services would be feasible. Results will inform whether and how to design a fully powered randomized controlled trial to test the effects of a manualized version of the Family Partner Model on child maltreatment. The specific results of the pilot study will inform 1) randomization procedures, 2) data sources to be used, 3) sample size calculations, and 4) adaptations to the design and measures for a fully powered randomized controlled trial.

Read the detailed description

The objective is to assess the adaptability and acceptability of the Family Partner Intervention, and the feasibility of a future randomised controlled trial. Our specific research questions are:

  1. What is the adaptability, acceptability, and feasibility of the Family Partner intervention in a Norwegian municipal context?
  2. What are the experiences and possible outcomes of the Family Partner intervention?
  3. Is the trial design feasible for an RCT expansion?

The investigators will pilot a parallel randomized trial (RCT), allocated to two groups (treatment and control). Families that fit to the target group, will be invited to take part in the study. Each family which fit the inclusion criteria and consent to participate will be randomized with a 1:1 allocation to experimental and control groups. Each Family Partner can serve 5 families at a time, and the Family Partner will serve families from 6-18 months. As families complete the programme, new families will be recruited. Hence, the recruitment and randomization will be an ongoing process. Any changes to methods after pilot trial commencement will be reported along with study results.

In a future RCT, the objective is to evaluate the effectiveness of the Family Partner Intervention, i.e. whether introducing the intervention would improve the outcome of existing Child Welfare Services. Hence, the trial is a superiority trial, in which the Family Partner Intervention is hypothesized to be superior to existing service provision. The trial is designed according to an intention-to-treat principle, where all consented participants are included in the analyses, independent of their adherence to intervention.

Being tested
Family Partner

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Family PartnerBehavioural

    The Family Partner intervention is based on well-known elements for preventing child abuse and neglect, such as 1) high intensity intervention with home visitations, 2) coordination of services, 3) an ecological perspective, 4) parental guidance, and 5) an emphasis on a therapeutic relationship with parents to create trust, change and agency.

    Family Partners must have relevant professional background and education, such as social work, child welfare services and other health/welfare occupations. They must have a personal attitude for relation-based service delivery in a home-setting, a long work experience and in-depth knowledge of municipal welfare services.

    Each practitioner will follow five families. The estimated duration of the intervention is 12 months, but might go over longer stretches of time if it is considered beneficial for the families. The minimum duration of the intervention is 3 months.

Study groups in NCT04957394
Study groupRoleWhat they receive
Experimental (Family Partner)ExperimentalThe treatment group will receive six hours follow-up and support weekly. The service will be provided by a dedicated Family Partner.
Receives: Behavioral: Family Partner
Control groupNo interventionThe control group will receive default support from the child welfare services. The service will be "business as usual", provided by the local staff at the child welfare services.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Acceptability

    Intervention Rating Profile (IRP-15)

    Measured: Acceptability at 12 months

Secondary outcomes (1)
  1. Relationship between the Family Partner and the parents

    The Working Alliance Inventory (WAI)

    Measured: Change from Baseline WAI at 3, 6, 9, 12, 15 and 18 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jul 2021
  2. Study start1 Jan 2022
  3. Primary completion18 Sep 2024
  4. Study completion18 Sep 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
45 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04957394
Sponsor's protocol ID
804402
Acronym
FAMPART
Status last verified
Apr 2025
First submitted
28 Jun 2021
Last updated
11 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Finne J, Toge AG, Wiggen KS, Ekre M, Malmberg-Heimonen I, Pontoppidan M, Dion J, Tommeras T, Pedersen E. Results from a randomized controlled pilot trial of a home-visiting intervention to reduce child maltreatment. Pilot Feasibility Stud. 2025 Jun 3;11(1):77. doi: 10.1186/s40814-025-01659-9.

    PubMed 40462144
  • Pedersen E, Malmberg-Heimonen I, Finne J, Pontoppidan M, Dion J, Tommeras T, Toge AG. Family Partner: study protocol for a pilot randomised study of a home-visitation intervention in Norway. Scand J Public Health. 2024 Aug;52(6):761-768. doi: 10.1177/14034948231189773. Epub 2023 Aug 14.

    PubMed 37574994

Questions about this trial

What is this clinical trial studying?

A study testing Family Partner in people with Family and Parenting, run by Oslo Metropolitan University at 3 sites in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Acceptability (time frame: Acceptability at 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04957394, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in